eft ventricular (LV) remodeling involves expansion of the infarcted area, ventricular dilatation, and thinning of the ventricular wall after a myocardial infarction (MI). 1,2 The dynamic synthesis and breakdown of extracellular matrix (ECM) proteins may play an important role in myocardial remodeling. Remodeling after MI is associated with LV dilation, decreased cardiac function, and increased mortality. In the early stage immediately after MI, the infarcted region of the LV undergoes myocyte necrosis, apoptosis, and ECM reorganization. Alterations in the ECM, such as increased collagen accumulation and changes in matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinase (TIMPs), have been observed in the remote myocardium after MI. [3] [4] [5] The ECM sustains myocardial structure and functional properties and collagen turnover is controlled by specific MMPs and TIMPs under normal hemodynamic conditions. Changes in ECM composition have been shown to coincide with myocardial ischemia and dilated cardiomyopathy; 6 however, the underlying cellular and molecular changes are not yet completely understood.
mance. The remaining myocytes are unable to reconstitute the necrotic tissue, and the post-infarcted heart deteriorates with time. 7 Although surgical and interventional revascularization of the ischemic myocardium can treat angina, reduce the risk of further MI, and improve the function of viable myocardium, the viability of necrotic myocardium cannot be restored. Therefore, the search for new and effective therapeutic methods is warranted. In recent years, cell transplantation has emerged as a novel approach for generation of viable heart muscle cells. Experimental data show that transplantation of bone marrow stem cells or neonatal myocytes could regenerate functional myocardium and improve ventricular function in animals with MI. [8] [9] [10] [11] In the meantime, myogenic cells may provide elasticity to stabilize the infarct region and prevent infarct thinning, chamber dilatation, and congestive heart failure. 12 In the present study, we set out to isolate and expand a highly purified population of adult rat bone marrow derived stem cells (MSCs), and to test the hypothesis that MSCs could prevent remodeling, improve heart function and reduce ECM gene expression after their transplantation into infarcted myocardium.
Chinese laws concerning the protection and control of animals, standards related to care and management of experimental animals, and guidelines on animal experiments set by the Chinese government were strictly followed throughout the experiments.
MI
MI was induced by ligation of the left anterior descending coronary artery (LAD) as described earlier by Pfeffer et al 13 with some modifications. Briefly, rats were anesthetized with a combination of ketamine (30 mg/kg ip) and xylazine (10 mg/kg ip), and mechanically ventilated. A left thoracotomy was performed through the 4th and 5th intercostal spaces. After the pericardium was opened, the LAD was ligated approximately 2 mm from its origin using 5-0 silk. The chest was closed with 2-0 silk. The sham-operated group underwent an identical surgery with neither ligation of the LAD nor cell transplantation.
Cell Culture and Implantation
MSC isolation was performed as described elsewhere. 14 Briefly, bone marrow cells were aspirated from the femur and tibia by flushing the bone marrow cavity with sterile phosphate-buffered saline (PBS). The cell suspension was passed through a density gradient to eliminate unwanted cell types. After a homogeneous cell suspension was achieved, the cells were centrifuged (1,500 rpm for 5 min), resuspended in DMEM (Dulbecco's modified Eagle's medium, purchased from GibcoBRL) supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin. The MSCs were isolated on the basis of their ability to adhere to the culture plate. At 90% confluence, the cells were trypsinized (0.25% trypsin-EDTA, Sigma, St Louis, MO, USA) and then passaged. Before implantation, MSCs were labeled with 5'-bromo-2-deoxyuridine (BrdU; Sigma) as described previously. 13 The cells were incubated with 1% BrdU for 24 h in complete culture medium.
Cells were obtained by detaching them from the culture plates and resuspending them in serum-free medium with a density of 10 7 cells/ml. Cell transplantation was performed within 30 min after induction of MI. MSC suspension (30 l) was injected into 3 sites with a 26-gauge needle bent at an angle of 45°, one site within the infarct area and 2 in the myocardium bordering the ischemic area. Medium-treated animals underwent the same MI operation, but were only injected with the equivalent volume of cell-free medium. The rats were randomly divided into 3 groups: Group 1 (n= 20): MI + Medium, MI rats receiving only medium injection; Group 2 (n=20): MI + MSC, MI rats receiving MSC injection; Group 3 (n=20): sham-operated control rats.
LV Hemodynamic Evaluation
Both MI and sham-operated rats were studied by invasive hemodynamic evaluation. The rats were anesthetized as described. After anesthesia was achieved, the right carotid artery was exposed and a PE-10 catheter (Becton Dickinson, Mountain View, CA, USA) connected to a pressure transducer was inserted retrogradely from the carotid artery to the LV cavity to measure LV systolic pressure (LVSP) and LV peak velocities (dP/dtmax), which were recorded on a polygraph system (model RM6000; Nihon Koden, Tokyo, Japan).
Determination of Infarct Size
At the end of the experimental period, animals were killed with an overdose of pentobarbital sodium, followed by intravenous KCl injection to arrest the heart in diastole. The heart was removed from the chest, the atria were trimmed from the ventricles, and the right and left ventricles plus septum were separated and weighed. The tissues were then immersed and fixed in 10% buffered formalin. Each heart was sliced in cross-section at 4 levels from the apex to the base and prepared for routine histology. The sections from each level were stained with 1% triphenyltetrazolium chloride (TTC) solution for 20 min. For the measurement of infarct size, expressed as a percentage of the LV, slices were placed under a video microscope with a 20-fold enlargement lens. The endocardial and epicardial circumferences of the infarcted tissue and of the LV were determined using image analysis software (Cyber-view, Cervus International). MI size was calculated as the average of all slices and expressed as a percentage of length. Infarct size was calculated by dividing the sum of the planimetered endocardial and epicardial circumferences of the infarcted area by the sum of the total epicardial and endocardial circumferences of the LV. 15 The person who measured the infarct size was unaware of the treatment group.
Picrosirius Red Staining
LV circumferential sections (≈2 mm) were maintained in fixative for 48 h and then embedded in paraffin. Deparaffinized 5-m-thick sections were incubated for 1 h with picrosirius red (Mobay Chemical company, USA). Stained sections were imaged using polarized light, which causes clear demarcation of the fibrillar collagens. 16 LV crosssections were divided into 8 equal sections, digitized using a ×10 objective, and analyzed (Image Pro Plus, Media Cybernetics, Silver Spring, MD, USA). Percentage area of extracellular staining was computed from 16 random fields spanning the entire thickness of the LV wall, providing a composite measure of interstitial, perivascular, and replacement fibrosis.
Histological and Immunohistochemical Analyses
Histological analysis used hematoxylin-eosin, immunohistochemical staining, and capillary density analyses.
Heart sections embedded in paraffin were cut into 5-m slices and stained with H&E for histological examination. Serial sections were immunolabeled with antibodies antiBrdU (Zymed; 1:100 dilution) and anti-factor VIII (Zymed; 1:50 dilution) followed by incubation with secondary antibody conjugated with peroxidase at 37°C for 45 min. The samples were washed 3 times (15 min each) with PBS and then immersed in diaminobenzidine (DAB) (2 mg/ml DAB, 0.03% H2O2 in 0.02 ml/L phosphate buffer) solution for 15 min. After washing with PBS, the samples were coverslipped and photographed.
The capillary density was assessed in 15 animals (5 in each group) killed at day 28 after implantation. The number of capillary vessels was counted blind on 60 sections (2 sections per slide, 2 slides per heart) in the infarct and periinfarct areas of all animals after staining with anti-factor VIII using a light microscope at ×400 magnification. Five high-power fields in each section were randomly selected, and the number of vessels in each field was averaged and expressed as the number of vessels per high-power field (0.2 mm 2 ).
Semiquantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR)
RNA was extracted with TRIZOL reagent (Invitrogen) as described by the manufacturer. RT-PCR was carried out according to the protocol. Total RNA (1 g) extracted from the LV myocardium was reverse transcripted with MMLV reverse transcriptase (Promega) and random primers (Promega) at 37°C for 1 h. PCR amplification was per- Injection of bone marrow derived stem cell (MSC) into ischemic rat heart reduces infarct volume and heart/body weight (BW) ratio. (A) Infarct size is reduced by MSC transplantation 28 days after ligation. (B) Heart/BW ratio was reduced by MSC transplantation into the infarcted heart. Heart/BW, heart/BW ratio. Significance is indicated by the following: *p<0.05 vs Sham-operated control; **p< 0.01 vs Sham-operated control; † p<0.05 vs myocardial infarction (MI) + Medium group; ‡ p<0.01 vs MI + Medium group.
formed with the same amount of first-strand cDNA using Taq DNA polymerase (Promega). Three different series of RNA samples from each group were assayed. The sequences of the primers is shown in Table 1 . The products of PCR-amplified samples were visualized on 1.5% agarose gels using ethidium bromide. Each specific mRNA band was normalized with a band of relative internal reference‚ -actin mRNA. The relative intensity of the band of interest was analyzed with Scan-Gel-It software (Silk Scientific) and expressed as the ratio a: -actin mRNA band.
In Situ Hybridization
The probes used for this study were MMP-1, a 2.05 kb Hind III/Sma I fragment from human MMP-1 cDNA (American Type Culture Collection, Manassas, VA, USA); collagen type I, a 4.6 kb EcoR I fragment from human collagen type I cDNA; collagen type III, a 4.5 kb EcoR I fragment from human collagen type III cDNA; TIMP-1 (a 348 bp cDNA segment) and transforming growth factor (TGF)-1 (a 614 bp cDNA segment), created with rat heart mRNA; the primers are shown in Table 1 .
The probes were labeled with digoxigenin-11-dUTP and dATP using a random primer labeling and detection kit (Roche Diagnostics GmbH Roche Applied Science; Mannheim, Germany). After deparaffinization and routine treatment, the sections were exposed to 5 g/ml proteinase-K (Sigma) for 20 min. Prehybridization with hybridization solution was performed for 1 h at 42°C. Hybridization with labeled probes was carried out overnight in a humidified chamber at 42°C. After hybridization, the sections were washed at 42°C with 2 changes of 2× SSC (sodium citrate buffer), one change of 1× SSC and one change of 0.5× SSC for 15 min, each. The hybridization signal was detected by anti-digoxigenin antibody conjugated with alkaline phosphatase, followed by incubation in nitro-blue tetrazolium chloride/5-bromo-4-chloro-3-inodyl-phosphate (Roche Diagnostics GmbH Roche Applied Science; Mannheim, Germany) color substrate solution.
As controls, the procedure described above was carried out using either sense probe or without any probes.
Western Blot
The frozen tissue samples were cut into small pieces and homogenized in 10 vol. of homogenization buffer. Protein expression was analyzed by Western blot: 20 g of LV tissue protein was separated on a 10% sodium dodecyl sulfate-polyacrylamidegel electrophoresis and blotted on nitrocellulose membrane (Bio-Rad). The protein blots were incubated at 4°C overnight with specific antibodies (anticollagen types I and III, anti-TGF-1) as mentioned before and actin (Santa Cruz), with a dilution of 1:1,000. Blots were incubated with horseradish peroxidase-conjugated secondary antibody, and the signal was detected with enhanced chemiluminescence (Amersham). Every Western blot was performed twice, with a variability between measurements of <10%.
Statistical Analysis
All values are expressed as mean ± SEM. Comparisons between groups were analyzed by one-way analysis of variance (ANOVA, StatView 4.0). For post hoc analysis, the Bonferroni test was applied. A p-value of less than 0.05 was considered statistically significant.
Results

MSC Culture and Labeling
Seven days after seeding of the MSCs in culture plates, adherent cells in small colonies with fibroblast-shaped morphology were observable under a phase-contrast microscope. The hematopoietic cells, which constituted the majority of the cells, do not stick to the culture plate and were removed with subsequent medium changes. The cells with fibroblast-like morphology were also maintained after cell passages and throughout the culture period. After 1 week, the adherent cells reached 90% confluence and were passaged for the first time. The in vitro BrdU labeling efficiency of the cells was approximately 70%.
Hemodynamics and General Characteristics
Invasive in vivo hemodynamic evaluation was performed in rats 7 and 28 days after permanent MI by distal LAD ligation and at the same time points in the sham-operated controls. As shown in Fig 1, LVSP and dP/dtmax in the MSC-treated group increased significantly compared with the MI group. These results indicated that both systolic and diastolic function was well preserved in the MSC treated group after MI, demonstrating that MSC transplantation could lead to significant improvement in heart function.
TTC staining showed fibrosis in the infarcted area in all experimental groups. As shown in Fig 2, the volume of the LV infarct was maximal after medium injection. Infarct size was significantly smaller in the MSC-treated group than in the MI group 28 days after ligation. The heart/body weight ratio was clearly increased in the experimental group compared with the sham-operated group, suggesting that compensatory myocardial hypertrophy might have occurred in non-ischemic myocardial tissue after MI. However, the heart/body weight ratio was significantly decreased 28 days after MI in the rats transplanted with MSC compared 
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with the animals receiving medium injection. These data indicate that MSC transplantation significantly reduced not only the severity of LV hypertrophy, but also the area of infarction in the rats with MI. Fig 3 shows the results of picrosirius red staining. In the MI rats the collagen volume fraction significantly increased compared with sham-operated controls. Total collagen volume fraction was reduced in the MSC treated group after MI. As shown in Fig 3, immunostaining for BrdU confirmed the survival of implanted MSC in the area around the infarct area (border zone). Fig 4 shows the results of in situ hybridization for collagen types I and III, MMP-1, TIMP-1 and TGF-1 on day 28 after coronary ligation, and these were similar to the results on day 7 after MI. Low-density and uniformly distributed mRNA of collagen types I and III was observed in the sham-operated group. As shown in Figs 4 and 5, the mRNA expression of both collagen type I and type III was significantly induced in the infarcted myocardium at day 7 after MI. Despite a decline toward the baseline level, the induction of abundant mRNA of collagen types I and III was sustained to at least day 28 after MI. In situ hybridization revealed scattered signals for collagen type I and for collagen type III mRNA in the intercellular spaces and perimysial spaces of the sham-operated hearts. The intensity and distribution of signals for the expression of collagen type I and type III mRNA in the sham-operated hearts remained unchanged throughout the duration of this study. MSC transplantation significantly decreased collagen gene expression in the infarcted myocardium, and the effect was more discernible for collagen type I than for type III. The mRNA of both collagen type I and type III was significantly reduced in the MSC rats compared with the MI only group. The immunostaining for collagen type I and type III strengthened the results (Fig 6) . Our data indicated that LV remodeling could be inhibited by MSC transplantation.
MSC Transplantation Reduces Expressions of Collagen Types I and III
Capillary Density
In the infarct area, capillary density was significantly higher in the MSC transplantation group than in the control group at day 28 post implantation (Fig 7) . Additional experiments performed on day 7 after implantation using 1 rat from each group showed that this difference can be observed after the 7th day (data not shown). Conversely, in the peri-infarct area, the capillary density at day 28 was not significantly different between the groups (Fig 7) .
Effects of MSC Transplantation on MMP-1, TIMP-1 and TGF-1 Gene Expressions
As shown in Figs 4 and 5, compared with the controls, the optical density of MMP-1 mRNA was low and remained unchanged in all experimental groups on days 7 and 28 after coronary ligation.
Weak TIMP-1 mRNA expression was observed in the sham-operated hearts. After MI, the level of TIMP-1 mRNA transcripts was markedly increased on day 7, and then declined but was still significantly higher than that in the sham-operated group on day 28 (Figs 4,5) . Transplantation of MSCs significantly decreased TIMP-1 mRNA levels compared with the untreated MI control group.
TGF-1 mRNA level was low in the sham-operated group during the period of our experiments. After MI, TGF-1 mRNA levels markedly increased around necrotic tissue on day 7 and gradually decreased thereafter, but were significantly higher than that in the sham-operated controls on day 28. The increase in the TGF-1 mRNA level was most evident at the site of MI. However, transplantation of MSC significantly lowered the TGF-1 mRNA levels in the LV of the MI rats. The immunostaining for TGF-1 showed the similar results (Fig 6) .
Discussion
Cell transplantation may be an alternative treatment for MI in the future. Bone marrow has multipotential progenitor cells that can differentiate into muscle, cartilage, bone, fat, and tendon under different conditions. 8 The main feature of MSCs is their ability to be isolated from adult bone marrow aspirate and expanded ex vivo before implantation. Many groups have reported that putative MSCs derived from bone marrow can differentiate into cardiac muscle in vitro and in vivo. [17] [18] [19] [20] The cardiac milieu has an important effect on myogenesis. Fukuhara et al have studied the cardiac environment in vitro during research into cell transplantation in the heart and reported that direct cell-cell interaction with cardiomyocytes was important for bone marrow cells to differentiate into cardiomyocytes. 21 Thus, in order to deliver the donor cells to the damaged segment of the myocardium, direct local injection of donor cells has been the predominant technique used in both experimental and clinical cellular cardiomyoplasty. The donor cells have been injected with a needle directly into the myocardial scar, or into the peri-infarct zone, the latter allowing the donor cells to come into contact with native cardiomyocytes, which are thought to promote milieu-dependent differentiation of adult stem cells.
Our study showed that MSC transplantation attenuated LV dilation and cardiac hypertrophy in the non-infarcted region, and improved LVSP at 28 days after MI. The heart/body weight ratio in MI + MSC rats decreased after LAD ligation; however, LV +dP/dtmax and -dP/dtmax were significantly increased compared with the MI only group. Infarct size in the MI + MSC group was decreased by approximately 10% over the MI only group 28 days after MSC transplantation. Consequently, the reduced LV weights in the MSC transplantation group indicated that reactive hypertrophy was prevented. Relative improvement of systolic function was induced, suggesting that the pump- ing ability of the LV was significantly improved. During the early phase of MI, the heart attempts hemodynamic compensation at the expense of ventricular dilatation. Chronic, continued hemodynamic stress leads to pathological hypertrophy and progressive dilatation. 22, 23 Ogawa et al reported that peripheral blood stem cell transplantation may transiently improve the function of the failing heart. 24 Our data showed that MSC transplantation could not only result in significant improvement in infarct size, but also improve heart function at an early stage of MI. It may also contribute to the higher capillary density that was observed at day 28 after implantation in the MSC group. Such capillary density is thought to maintain the viability of the grafted cells and residual cardiomyocytes for successful cellular cardiomyoplasty.
Collagen types I and III are major components of the cardiac ECM. LV remodeling after MI contributes significantly to LV dilation and dysfunction, and disability and death. Changes in the non-infarcted myocardium include hypertrophy of cardiomyocytes and an increase in fibrillar collagens I and III. These microscopic alterations in the myocardial architecture in the non-ischemic myocardium are thought to be responsible for ventricular dysfunction in the chronic phase. In the present study, significant increases in the mRNA for collagen types I and III were detected 7 and 28 days after coronary ligation, whereas in the MI + MSC group these increases were rather moderate. Overall, our findings on the mRNA expression levels of collagen types I and III were similar to previous studies. 25, 26 The results revealed that local implantation of MSC in the myocardial ischemic region could markedly reduce the collagen content.
MMP-1 plays a major role in the degradation of collagen types I and III in both normal and repairing tissue. An upregulation of MMP gene expression and subsequent degradation of the myocardial matrix have been shown to be associated with both MI and dilated cardiomyopathy. 6, 27, 28 Soejima et al have shown that increased serum MMP-1 concentration predicted advanced LV remodeling in patients with acute MI. 29 Inhibition of MMPs led to a decrease in LV dilation and wall stress. 30 However, in the present study we did not find any difference in the level of MMP-1 among the 3 experimental groups on either day 7 or 28 after coronary ligation. We speculate that the MMP-1 expression is probably be enhanced soon after MI and declines to the normal level before day 7. The early rise in the level of MMP-1 synthesis in the infarcted MI coincides with collagen degradation in the necrotic myocardium, as demonstrated by Sun et al. 25 The subsequent inactivation of MMP-1 synthesis in the infarcted heart might contribute to collagen accumulation.
The extracellular activity of MMP-1 could be partially regulated by TIMP-1. TGF-1 has been found to upregulate TIMP-1 synthesis. The relationship between TIMP and MMP activity during progressive fibrosis is critical to any assessment of matrix degradation during fibrosis. Our study showed that TIMP-1 was significantly increased in the MI group, but increased more gradually in the MI + MSC group. Whether TIMP-1 upregulation produces a proportionate decrease in MMP activity is unclear.
TGF-1 is well known as an important regulator of tissue fibrogenesis by stimulating fibroblast proliferation, promoting collagen synthesis, and inhibiting collagen degradation. 25, 31 TGF-1 is capable of stimulating the proliferation of mesenchymal cells and is a powerful initiator of the production of ECM components in a variety of tissue types. 32 It has been shown to be responsible for myocardial fibrosis and maladaptive ECM remodeling. Upregulation of the TGF-1 expression level was observed during the transition from stable hypertrophy to heart failure, which is thought to initiate increased interstitial fibrosis. 33 In the present study, our data indicated that TGF-1 mRNA levels significantly increased in the infarcted rat heart and MSC transplantation could decrease that expression. Although it is clear that TGF-1 intermediates myocardial fibrosis in the remote non-ischemic myocardium, the underlying mechanism that regulates TGF-1 is yet to be explored.
In summary, our results demonstrate that MSC transplantation could inhibit LV remodeling, improve heart function and reduce ECM gene expression in the non-infarcted myocardium. In addition, it is feasible to transplant MSC into a model of acute MI. MSC transplantation could exert a marked inhibitory effect on pathological myocardial remodeling, which may be important in mediating the therapeutic benefit.
